GILD
Gilead Sciences
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: GILD
- PE Ratio
As of Jul 30, 2026, the Gilead Sciences stock's PE ratio is 17.69. This results from the current EPS of $7.42 and stock price of $131.28. The P/E ratio has a decrease of 7% from the past four quarters average of 18.9.
GILD PE ratio history
The PE ratio of Gilead Sciences has averaged 74.84 over the last ten years. The current PE ratio of 17.69 is 76% below the historical average. Over the past ten years, GILD's PE ratio was at its highest in the Sep 2024 quarter at 838.4, when the stock price was $83.84 and the EPS was $0.1. The lowest value was in the Dec 2016 quarter, when it reached 7.1 with a price of $71.61 and an EPS of $10.08.
Gilead Sciences PE ratio by year
Maximum annual increase: 3,700.39% in 2020
Maximum annual decrease: -97.49% in 2021
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 17.94 | -92.62% | $122.74 | $6.84 |
| 2024 | 243.08 | 1,262.56% | $92.37 | $0.38 |
| 2023 | 17.84 | -23.96% | $81.01 | $4.54 |
| 2022 | 23.46 | 60.25% | $85.85 | $3.66 |
| 2021 | 14.64 | -97.49% | $72.61 | $4.96 |
| 2020 | 582.6 | 3,700.39% | $58.26 | $0.1 |
| 2019 | 15.33 | 2.96% | $64.98 | $4.24 |
| 2018 | 14.89 | -26.43% | $62.55 | $4.2 |
| 2017 | 20.24 | 185.07% | $71.64 | $3.54 |
| 2016 | 7.1 | -13.2% | $71.61 | $10.08 |
| 2015 | 8.18 | -31.03% | $101.19 | $12.37 |
| 2014 | 11.86 | -68.25% | $94.26 | $7.95 |
| 2013 | 37.36 | 73.93% | $75.1 | $2.01 |
| 2012 | 21.48 | 89.92% | $36.73 | $1.71 |
| 2011 | 11.31 | 5.5% | $20.47 | $1.81 |
Gilead Sciences PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 18.78 | 4.68% | $139.37 | $7.42 |
| Dec 2025 | 17.94 | 5.22% | $122.74 | $6.84 |
| Sep 2025 | 17.05 | -22.32% | $111 | $6.51 |
| Jun 2025 | 21.95 | -6.56% | $110.87 | $5.05 |
| Mar 2025 | 23.49 | -90.34% | $112.05 | $4.77 |
| Dec 2024 | 243.08 | -71.01% | $92.37 | $0.38 |
| Sep 2024 | 838.4 | 938.65% | $83.84 | $0.1 |
| Jun 2024 | 80.72 | -55.92% | $68.61 | $0.85 |
| Mar 2024 | 183.13 | 926.51% | $73.25 | $0.4 |
| Dec 2023 | 17.84 | 12.13% | $81.01 | $4.54 |
| Sep 2023 | 15.91 | -9.4% | $74.94 | $4.71 |
| Jun 2023 | 17.56 | -5.59% | $77.07 | $4.39 |
| Mar 2023 | 18.6 | -20.72% | $82.97 | $4.46 |
| Dec 2022 | 23.46 | 1.56% | $85.85 | $3.66 |
| Sep 2022 | 23.1 | 23.33% | $61.69 | $2.67 |
GILD Price vs fair value
GILD average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of GILD is below the 3, 5 and 10-year averages.
PE comparison
Gilead Sciences's P/E of 17.69 is below the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 26.12, Gilead Sciences's P/E is 32% lower.
GILD PE vs peers
Compared to its peer stocks LLY and JNJ, GILD's PE ratio stands lower. Gilead Sciences's PE ratio is trading below the peer group average of 30.74.
| Stock name | PE ratio | Market cap |
|---|---|---|
| GILD Gilead Sciences Inc | 17.52 | $161.4B |
| PFE Pfizer Inc | 19.16 | $143.03B |
| QGEN Qiagen NV | 22.1 | $8.55B |
| AMGN AMGEN Inc | 26.46 | $206.78B |
| VRTX Vertex Pharmaceuticals Inc | 27.87 | $120.32B |
| JNJ Johnson & Johnson | 29.5 | $620.72B |
| BIIB Biogen Inc | 36.01 | $30.22B |
| ILMN Illumina Inc | 36.24 | $30.27B |
| MRK Merck & Co Inc | 36.66 | $323.28B |
| LLY Lilly(Eli) & Company | 40.54 | $1.08T |
| ABBV Abbvie Inc | 124.37 | $446.06B |
Frequently asked questions
What is Gilead Sciences's PE ratio?
GILD stock has a price to earnings ratio of 17.69 as of Jul 30, 2026.
What is the 3-year average PE ratio for Gilead Sciences (GILD)?
Over the last 3 years, the average price to earnings ratio for GILD stock is 134.39.
What is the 5-year average PE ratio for Gilead Sciences (GILD)?
Over the last 5 years, the average price to earnings ratio for GILD stock is 85.41.
What is the highest PE ratio for GILD?
In the last ten years, the Sep 2024 quarter recorded the highest quarterly PE ratio at 838.4.
How does the current PE ratio for GILD compare to its historical average?
GILD's price to earnings ratio is currently 76% below its 10-year historical average.
How is GILD's PE ratio calculated (Gilead Sciences PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jul 30, 2026), Gilead Sciences's stock price is $131.28. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $7.42. Therefore, Gilead Sciences's P/E ratio for today is 17.69. PE RATIO(17.69) = STOCK PRICE($131.28) / TTM EPS($7.42)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.